* Sales +34% vs EBIT adj. EUR 3.9m vs. ABGSCe 0.7m * Orders in line vs.
Redeye updates its estimates and valuation after OEM’s Q4 2025 report.
Redeye presents its preview for Paxman’s Q4 2025 report, due on February 27.
Recent years have been quite volatile for Incap. Quarterly revenue growth fluctuated between +40% an...
* Q4: +27% sales growth, 1.5% EBITDA margin * '26e-'27e EBITDA up 2-3% * Continues to show improveme...
* Accretive SBBs set to continue in H1'26 * Room for M&A to drive earnings growth * 2026e P/CEPS 11x...
* Strong Q4, with EBIT 82% ahead of our forecast * We lift '26e EBIT by 17% on positive sales revisi...
Redeye was surprised to see organic sales growth of 10% in the fourth quarter.
Flowscape avslutar 2025 med historiskt positiv EBIT på årsbasis (2,2 mkr).
Redeye views the Q4 report as a sizable top-line beat, exceeding forecasts by 110% despite the quart...
Redeye provides a research update following the Q4 report published by ExpreS2ion earlier today.
Thunderful Group is reporting its final quarter and full year as a publicly listed company.
Redeye considers Guldbrev’s Q4 report to be a mixed bag, where the company outgrew our expectations,...
* Sales +SEK 17m, EBITDA -SEK 1.2m vs. ABGSCe * '26e-'27e EBITDA estimates likely flat * Share to fo...
Hyresintäkterna föll 1% för helåret till 2 271 mkr pga avyttringar och vakanser, men driftnettot höl...
Redeye considers GomSpace’s Q4 report to be solid, with 76% y/y growth, which was slightly better th...
Redeye provides its initial take on Navigo’s Q4 2025 report, which came in slightly better on sales ...
Redeye is optimistic after Medivir's Q4 report. The new programme in osteogenesis imperfecta holds s...
Redeye comments on Fable Media Group’s Q4 results, which saw revenue excluding Brazil continuing its...
Starbreeze’s sales came in much lower than expected.